Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus-infected subjects

Blood

Volumn 96, Issue 3, 2000, Pages 785-793

  Mitsuyasu, R T ^a   Anton, P A ^a   Deeks, S G ^a   Scadden, D T ^a   Connick, E ^a   Downs, M T ^a   Roberts, A ^a   Bakker, M R ^a   June, C H ^a   Jalali, S ^a   Lin, A A ^a   Pennathur Das, R ^a   Hege, K M ^a  

^a CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE INSERTION; GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD;

EID: 0034254611     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.3.785.015k10_785_793     Document Type: Article

References (46)

1. Cytotoxic T cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
2. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo
3. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1) specific cytotoxic T lymphocyte (CTL) response at different stages of HIV- 1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
4. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
5. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors
6. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
7. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 alleles
8. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
9. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques
10. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
11. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
12. Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease
13. HIV type 1-specific helper T cells: A critical host defense
14. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
15. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
16. Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant
17. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
18. Use of gene-modified virus-specific T lymphocytes to control Epstein- Barr virus-related lymphoproliferation
19. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
20. Genetic modification of T-cell clones for therapy of human viral and malignant diseases
21. T cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
22. Transfer of HIV-1 specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
23. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients
24. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
25. Targeting of human immunodeficiency virus-infected celts by CD8+ T lymphocytes armed with universal T-cell receptors
26. Repression of MHC class I gene promoter activity by two-exon Tat of HIV
27. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
28. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules
29. Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells
30. In vivo persistence of genetically modified HIV-1-specific syngeneic lymphocytes in HIV-1-discordant identical twins
31. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation
32. kat. a high-efficiency retroviral transduction system for primary human T lymphocytes
33. A Mus dunni cell line that lacks sequences closely related to endogenous routine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic and mink cell focus-forming viruses
34. Molecular cloning and characterization of the HTLV-III virus associated with AIDS
35. Increased expression of chemokine receptors on mucosal versus circulating CD4+ T cells in seronegative controls
36. Quantitative assessment of tissue viral burden using a single intestinal biopsy
37. HIV-1 is detectable in mucosal biopsies from patients with undetectable plasma viral loads
38. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
39. Report of the NIH panel to define principles of therapy of HIV infection
40. Controlled trial of interleukin-2 in patients infected with the human immunodeficiency virus
41. Clinical studies of regional and systemic gene therapy with autologous CC49-ζ modified T cells in colorectal cancer metastatic to the liver
42. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells
43. Cell processing improvements and co-transduction of CD4 and CD8 T cells for HIV gene therapy
44. Critical role for β7 integrins in formation of the gut-associated lymphoid tissue
45. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
46. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients